HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis.

AbstractBACKGROUND:
Infection with Helicobacter pylori, a high-risk factor for gastric cancer, is frequently associated with chronic inflammation through activation of nuclear factor κB (NF-κB). Trefoil factor 1 (TFF1) is a constitutively expressed protein in the stomach that has tumor-suppressor functions and plays a critical role in maintaining mucosal integrity. This study investigated the role of TFF1 in regulating the proinflammatory response to H. pylori infections.
METHODS:
For in vitro studies, immunofluorescence, luciferase reporter assays, Western blots, and quantitative real-time polymerase chain reaction were performed to investigate the activation of NF-κB and its target genes in response to infections with H. pylori strains J166 and 7.13. In addition, Tff1-knockout (KO) and Tff1-wild-type mice were used for infections with the H. pylori strain called premouse Sydney strain 1.
RESULTS:
The reconstitution of TFF1 expression in gastric cancer cells significantly suppressed H. pylori-mediated increases in NF-κB-p65 nuclear staining, transcriptional activity, and expression of proinflammatory cytokine genes (tumor necrosis factor α, interleukin 1β, chemokine [C-X-C motif] ligand 5, and interleukin 4 receptor) that were associated with reductions in the expression and phosphorylation of NF-κB-p65 and IκB kinase α/β proteins. The in vivo studies using the Tff1-KO mouse model of gastric neoplasia confirmed the in vitro findings. Furthermore, they demonstrated increases in chronic inflammation scores and in the frequency of invasive gastric adenocarcinoma in the Tff1-KO mice infected with H. pylori versus the uninfected Tff1-KO mice.
CONCLUSIONS:
These findings underscore an important protective role of TFF1 in abrogating H. pylori-mediated inflammation, a crucial hallmark of gastric tumorigenesis. Therefore, loss of TFF1 expression could be an important step in H. pylori-mediated gastric carcinogenesis.
AuthorsMohammed Soutto, Zheng Chen, Ahmed M Katsha, Judith Romero-Gallo, Uma S Krishna, M Blanca Piazuelo, M Kay Washington, Richard M Peek Jr, Abbes Belkhiri, Wael M El-Rifai
JournalCancer (Cancer) Vol. 121 Issue 24 Pg. 4348-58 (Dec 15 2015) ISSN: 1097-0142 [Electronic] United States
PMID26372254 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2015 American Cancer Society.
Chemical References
  • Chemokine CXCL5
  • Interleukin-1beta
  • Peptides
  • Receptors, Interleukin-4
  • Tff1 protein, mouse
  • Transcription Factor RelA
  • Trefoil Factor-1
  • Tumor Necrosis Factor-alpha
  • I-kappa B Kinase
Topics
  • Adenocarcinoma (genetics, immunology, microbiology)
  • Animals
  • Carcinogenesis (genetics)
  • Chemokine CXCL5 (immunology)
  • Gastric Mucosa (immunology, metabolism, microbiology)
  • Helicobacter Infections (genetics, immunology)
  • Helicobacter pylori
  • Humans
  • I-kappa B Kinase (metabolism)
  • In Vitro Techniques
  • Inflammation
  • Interleukin-1beta (immunology)
  • Mice
  • Mice, Knockout
  • Peptides (genetics)
  • Phosphorylation
  • Real-Time Polymerase Chain Reaction
  • Receptors, Interleukin-4 (immunology)
  • Stomach (immunology, microbiology)
  • Stomach Neoplasms (genetics, immunology, microbiology)
  • Transcription Factor RelA (metabolism)
  • Trefoil Factor-1
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: